Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii

被引:25
作者
Cheng, Jiaqi [1 ]
Yan, Jun [1 ]
Reyna, Zeferino [1 ]
Slarve, Matt [1 ]
Lu, Peggy [1 ]
Spellberg, Brad [2 ]
Luna, Brian [1 ]
机构
[1] USC, Dept Mol Microbiol & Immunol, Keck Sch Med, Los Angeles, CA 90007 USA
[2] Los Angeles Cty USC LAC Usc Med Ctr, Los Angeles, CA USA
关键词
Acinetobacter baumannii; antibiotic resistance; colistin; rifabutin; BACTERIA;
D O I
10.1128/AAC.02204-20
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recently, we reported rifabutin hyperactivity against Acinetobacter baumannii. We sought to characterize potential interactions between rifabutin and colistin, the last-resort drug for carbapenem-resistant infections. Rifabutin and colistin were synergistic in vitro and in vivo, and low-dose colistin significantly suppressed emergence of resistance to rifabutin. Thus, this combination is a promising therapeutic option for highly resistant A. baumannii infections.
引用
收藏
页数:5
相关论文
共 10 条
[1]  
CDC, 2019, Antibiotic resistance threats report
[2]   Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial [J].
Durante-Mangoni, Emanuele ;
Signoriello, Giuseppe ;
Andini, Roberto ;
Mattei, Annunziata ;
De Cristoforo, Maria ;
Murino, Patrizia ;
Bassetti, Matteo ;
Malacarne, Paolo ;
Petrosillo, Nicola ;
Galdieri, Nicola ;
Mocavero, Paola ;
Corcione, Antonio ;
Viscoli, Claudio ;
Zarrilli, Raffaele ;
Gallo, Ciro ;
Utili, Riccardo .
CLINICAL INFECTIOUS DISEASES, 2013, 57 (03) :349-358
[3]   Evaluation of colistin as an agent against multi-resistant in Gram-negative bacteria [J].
Li, J ;
Nation, RL ;
Milne, RW ;
Turnidge, JD ;
Coulthard, K .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (01) :11-25
[4]   A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii [J].
Luna, B. ;
Trebosc, V ;
Lee, B. ;
Bakowski, M. ;
Ulhaq, A. ;
Yan, J. ;
Lu, P. ;
Cheng, J. ;
Nielsen, T. ;
Lim, J. ;
Ketphan, W. ;
Eoh, H. ;
McNamara, C. ;
Skandalis, N. ;
She, R. ;
Kemmer, C. ;
Lociuro, S. ;
Dale, G. E. ;
Spellberg, B. .
NATURE MICROBIOLOGY, 2020, 5 (09) :1134-1143
[5]   Natural history of Acinetobacter baumannii infection in mice [J].
Luna, Brian M. ;
Yan, Jun ;
Reyna, Zeferino ;
Moon, Eugene ;
Nielsen, Travis B. ;
Reza, Hernan ;
Lu, Peggy ;
Bonomo, Robert ;
Louie, Arnold ;
Drusano, George ;
Bulitta, Jurgen ;
She, Rosemary ;
Spellberg, Brad .
PLOS ONE, 2019, 14 (07)
[6]   Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis [J].
Nielsen, Travis B. ;
Pantapalangkoor, Paul ;
Luna, Brian M. ;
Bruhn, Kevin W. ;
Yan, Jun ;
Dekitani, Ken ;
Hsieh, Sarah ;
Yeshoua, Brandon ;
Pascual, Bryan ;
Vinogradov, Evgeny ;
Hujer, Kristine M. ;
Domitrovic, T. Nicholas ;
Bonomo, Robert A. ;
Russo, Thomas A. ;
Lesczcyniecka, Magda ;
Schneider, Thomas ;
Spellberg, Brad .
JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (04) :489-501
[7]   Multidrug-resistant bacteria: overcoming antibiotic permeability barriers of Gram-negative bacteria [J].
Savage, PB .
ANNALS OF MEDICINE, 2001, 33 (03) :167-171
[8]   The value of single-pathogen antibacterial agents [J].
Spellberg, Brad ;
Rex, John H. .
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (12) :963-964
[9]  
Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/S1473-3099(17)30753-3, 10.1016/s1473-3099(17)30753-3]
[10]   In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms [J].
Trebosc, Vincent ;
Schellhorn, Birgit ;
Schill, Julian ;
Lucchini, Valentina ;
Buhler, Jacqueline ;
Bourotte, Marilyne ;
Butcher, Jonathan J. ;
Gitzinger, Marc ;
Lociuro, Sergio ;
Kemmer, Christian ;
Dale, Glenn E. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (12) :3552-3562